{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T00:49:16Z","timestamp":1793666956696,"version":"4.5.1"},"reference-count":240,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Immunology"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.cellimm.2024.104826","type":"journal-article","created":{"date-parts":[[2024,4,23]],"date-time":"2024-04-23T01:17:46Z","timestamp":1713835066000},"page":"104826","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Leishmania vaccine development: A comprehensive review"],"prefix":"10.1016","volume":"399-400","author":[{"given":"Isha","family":"Saini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyoti","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9071-7950","authenticated-orcid":false,"given":"Sukhbir","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cellimm.2024.104826_b0005","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.immuni.2010.09.014","article-title":"Vaccines and the future of human immunology","volume":"33","author":"Germain","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.cellimm.2024.104826_b0010","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/s41591-021-01301-0","article-title":"Vaccine development for emerging infectious diseases","volume":"27","author":"Excler","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.cellimm.2024.104826_b0015","doi-asserted-by":"crossref","first-page":"12288","DOI":"10.1073\/pnas.1402981111","article-title":"Vaccines, new opportunities for a new society","volume":"111","author":"Rappuoli","year":"2014","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.cellimm.2024.104826_b0020","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S1471-4922(01)02155-9","article-title":"Vaccines, enzymes and malaria","volume":"18","author":"Rajan","year":"2002","journal-title":"TRENDS Parasitol."},{"key":"10.1016\/j.cellimm.2024.104826_b0025","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/nri3085","article-title":"Vaccines for the twenty-first century society","volume":"11","author":"Rappuoli","year":"2011","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cellimm.2024.104826_b0030","first-page":"null","article-title":"Systems vaccinology: learning to compute the behavior of vaccine induced immunity, Wiley Interdiscip","volume":"4","author":"Nakaya","year":"2012","journal-title":"Rev. Syst. Biol. Med."},{"key":"10.1016\/j.cellimm.2024.104826_b0035","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.immuni.2010.10.011","article-title":"A decade of vaccines: Integrating immunology and vaccinology for rational vaccine design","volume":"33","author":"D\u2019Argenio","year":"2010","journal-title":"Immunity."},{"key":"10.1016\/j.cellimm.2024.104826_b0040","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/ni.2039","article-title":"Immunological mechanisms of vaccination","volume":"12","author":"Pulendran","year":"2011","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cellimm.2024.104826_b0045","first-page":"6","article-title":"Leishmaniasis: a review","author":"Torres-Guerrero","year":"2017","journal-title":"F1000Res."},{"key":"10.1016\/j.cellimm.2024.104826_b0050","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.170165","article-title":"Shape, form, function and Leishmania pathogenicity: from textbook descriptions to biological understanding","volume":"7","author":"Sunter","year":"2017","journal-title":"Open Biol."},{"key":"10.1016\/j.cellimm.2024.104826_b0055","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.748325","article-title":"Determinants of innate immunity in visceral leishmaniasis and their implication in vaccine development","volume":"12","author":"Volpedo","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cellimm.2024.104826_b0060","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s13071-023-05651-1","article-title":"Leishmania tarentolae: a vaccine platform to target dendritic cells and a surrogate pathogen for next generation vaccine research in leishmaniases and viral infections","volume":"16","author":"Bandi","year":"2023","journal-title":"Parasit. Vectors"},{"key":"10.1016\/j.cellimm.2024.104826_b0065","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.4049\/jimmunol.170.6.3171","article-title":"Dendritic cell (DC)-based protection against an intracellular pathogen is dependent upon DC-derived IL-12 and can be induced by molecularly defined antigens","volume":"170","author":"Berberich","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellimm.2024.104826_b0070","doi-asserted-by":"crossref","first-page":"19841","DOI":"10.1038\/s41598-019-56305-1","article-title":"Differential immune response modulation in early Leishmania amazonensis infection of BALB\/c and C57BL\/6 macrophages based on transcriptome profiles","volume":"9","author":"Aoki","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cellimm.2024.104826_b0075","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s00430-021-00703-8","article-title":"Potential biomarkers of immune protection in human leishmaniasis","volume":"210","author":"Rostami","year":"2021","journal-title":"Med. Microbiol. Immunol."},{"key":"10.1016\/j.cellimm.2024.104826_b0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.109059","article-title":"Unwelcome prevalence of leishmaniasis with several other infectious diseases","volume":"110","author":"Saini","year":"2022","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.cellimm.2024.104826_b0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109098","article-title":"Functional aspects of T cell diversity in visceral leishmaniasis","volume":"117","author":"Jawed","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.cellimm.2024.104826_b0090","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.3389\/fimmu.2017.01437","article-title":"The equivocal role of Th17 cells and neutrophils on immunopathogenesis of leishmaniasis","volume":"8","author":"da C. Goncalves-de-Albuquerque","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cellimm.2024.104826_b0095","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cellimm.2016.07.004","article-title":"Role of pro-inflammatory cytokine IL-17 in Leishmania pathogenesis and in protective immunity by Leishmania vaccines","volume":"309","author":"Banerjee","year":"2016","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.cellimm.2024.104826_b0100","doi-asserted-by":"crossref","first-page":"691","DOI":"10.3390\/microorganisms9040691","article-title":"Leishmania protein kinases: important regulators of the parasite life cycle and molecular targets for treating leishmaniasis","volume":"9","author":"Efstathiou","year":"2021","journal-title":"Microorganisms"},{"key":"10.1016\/j.cellimm.2024.104826_b0105","article-title":"An overview on the therapeutics of neglected infectious diseases\u2014Leishmaniasis and Chagas diseases","volume":"9","author":"Chanda","year":"2021","journal-title":"Front. Chem."},{"key":"10.1016\/j.cellimm.2024.104826_b0110","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1016\/j.intimp.2011.05.008","article-title":"Vaccine candidates for leishmaniasis: a review","volume":"11","author":"Nagill","year":"2011","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.cellimm.2024.104826_b0115","doi-asserted-by":"crossref","first-page":"7036","DOI":"10.1016\/j.vaccine.2009.09.066","article-title":"Optimized subunit vaccine protects against experimental leishmaniasis","volume":"27","author":"Bertholet","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.cellimm.2024.104826_b0120","doi-asserted-by":"crossref","first-page":"144","DOI":"10.3389\/fimmu.2012.00144","article-title":"Adjuvants for Leishmania vaccines: from models to clinical application","volume":"3","author":"Raman","year":"2012","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cellimm.2024.104826_b0125","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1016\/j.ymthe.2021.03.020","article-title":"Safety and immunogenicity of ChAd63-KH vaccine in post-kala-azar dermal leishmaniasis patients in Sudan","volume":"29","author":"Younis","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.cellimm.2024.104826_b0130","first-page":"423","article-title":"Leishmaniasis vaccine candidates for development: a global overview","volume":"123","author":"Khamesipour","year":"2006","journal-title":"Indian J. Med. Res."},{"key":"10.1016\/j.cellimm.2024.104826_b0135","article-title":"Leishmania vaccines entered in clinical trials: a review of literature","volume":"10","author":"Moafi","year":"2019","journal-title":"Int. J. Prev. Med."},{"key":"10.1016\/j.cellimm.2024.104826_b0140","doi-asserted-by":"crossref","first-page":"3642","DOI":"10.1016\/j.vaccine.2005.02.015","article-title":"Leishmanization: use of an old method for evaluation of candidate vaccines against leishmaniasis","volume":"23","author":"Khamesipour","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.cellimm.2024.104826_b0145","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.trsl.2013.03.006","article-title":"New vaccines for neglected parasitic diseases and dengue","volume":"162","author":"Beaumier","year":"2013","journal-title":"Transl. Res."},{"key":"10.1016\/j.cellimm.2024.104826_b0150","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.vaccine.2011.11.005","article-title":"The development and clinical evaluation of second-generation leishmaniasis vaccines","volume":"30","author":"Duthie","year":"2012","journal-title":"Vaccine."},{"key":"10.1016\/j.cellimm.2024.104826_b0155","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1016\/S0140-6736(98)09552-X","article-title":"Randomised vaccine trial of single dose of killed Leishmania major plus BCG against anthroponotic cutaneous leishmaniasis in Bam, Iran","volume":"351","author":"Sharifi","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.cellimm.2024.104826_b0160","series-title":"Vet. Res. Forum, Faculty of Veterinary Medicine","first-page":"1","article-title":"An overview on Leishmania vaccines: a narrative review article","author":"Rezvan","year":"2015"},{"key":"10.1016\/j.cellimm.2024.104826_b0165","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.rvsc.2007.09.008","article-title":"Antigenicity of a whole parasite vaccine as promising candidate against canine leishmaniasis","volume":"85","author":"Giunchetti","year":"2008","journal-title":"Res. Vet. Sci."},{"key":"10.1016\/j.cellimm.2024.104826_b0170","doi-asserted-by":"crossref","first-page":"177","DOI":"10.4103\/0974-777X.62881","article-title":"Leishmaniasis vaccine: where are we today?","volume":"2","author":"Kedzierski","year":"2010","journal-title":"J. Glob. Infect. Dis."},{"key":"10.1016\/j.cellimm.2024.104826_b0175","doi-asserted-by":"crossref","first-page":"6759","DOI":"10.1016\/j.vaccine.2008.09.085","article-title":"First generation leishmaniasis vaccines: a review of field efficacy trials","volume":"26","author":"Noazin","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.cellimm.2024.104826_b0180","doi-asserted-by":"crossref","first-page":"B244","DOI":"10.1016\/j.vaccine.2012.11.080","article-title":"Case study for a vaccine against leishmaniasis","volume":"31","author":"Alvar","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.cellimm.2024.104826_b0185","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1016\/j.vaccine.2008.02.044","article-title":"Despite Leishvaccine and Leishmune\u00ae trigger distinct immune profiles, their ability to activate phagocytes and CD8+ T-cells support their high-quality immunogenic potential against canine visceral leishmaniasis","volume":"26","author":"Araujo","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.cellimm.2024.104826_b0190","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1016\/j.vaccine.2008.01.023","article-title":"Vaccines for leishmaniasis in the fore coming 25 years","volume":"26","author":"Palatnik-de-Sousa","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.cellimm.2024.104826_b0195","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.vaccine.2020.11.064","article-title":"Lipophosphoglycan-3 protein from Leishmania infantum chagasi plus saponin adjuvant: a new promising vaccine against visceral leishmaniasis","volume":"39","author":"de Oliveira Emerick","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.cellimm.2024.104826_b0200","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.vetpar.2015.01.003","article-title":"Canine Leishmania vaccines: still a long way to go","volume":"208","author":"Gradoni","year":"2015","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.cellimm.2024.104826_b0205","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1179\/146532806X152890","article-title":"Safety and immunogenicity of a candidate vaccine for visceral leishmaniasis (Alum-precipitated autoclaved Leishmania major + BCG) in children: an extended phase II study","volume":"26","author":"Khalil","year":"2006","journal-title":"Ann. Trop. Paediatr."},{"key":"10.1016\/j.cellimm.2024.104826_b0210","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.parint.2009.07.008","article-title":"Induction of cellular and humoral responses by autoclaved and heat-killed antigen of Leishmania donovani in experimental visceral leishmaniasis","volume":"58","author":"Nagill","year":"2009","journal-title":"Parasitol. Int."},{"key":"10.1016\/j.cellimm.2024.104826_b0215","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.trstmh.2005.04.002","article-title":"Failure of a killed Leishmania amazonensis vaccine against American cutaneous leishmaniasis in Colombia","volume":"99","author":"Velez","year":"2005","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.cellimm.2024.104826_b0220","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/S0035-9203(00)90239-6","article-title":"Safety and immunogenicity of a killed Leishmania (L.) amazonensis vaccine against cutaneous leishmaniasis in Colombia: a randomized controlled trial","volume":"94","author":"Velez","year":"2000","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.cellimm.2024.104826_b0225","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1016\/j.vaccine.2003.06.002","article-title":"Safety, immunogenecity, and efficacy of an autoclaved Leishmania amazonensis vaccine plus BCG adjuvant against New World cutaneous leishmaniasis","volume":"22","author":"Armijos","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.cellimm.2024.104826_b0230","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s12026-008-8016-2","article-title":"Persistent parasites and immunologic memory in cutaneous leishmaniasis: implications for vaccine designs and vaccination strategies","volume":"41","author":"Okwor","year":"2008","journal-title":"Immunol. Res."},{"key":"10.1016\/j.cellimm.2024.104826_b0235","doi-asserted-by":"crossref","first-page":"5451","DOI":"10.1016\/j.vaccine.2010.05.077","article-title":"Repeated inoculation of killed Leishmania major induces durable immune response that protects mice against virulent challenge","volume":"28","author":"Okwor","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.cellimm.2024.104826_b0240","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2180-10-181","article-title":"Comparison of BCG, MPL and cationic liposome adjuvant systems in leishmanial antigen vaccine formulations against murine visceral leishmaniasis","volume":"10","author":"Ravindran","year":"2010","journal-title":"BMC Microbiol."},{"key":"10.1016\/j.cellimm.2024.104826_b0245","doi-asserted-by":"crossref","first-page":"380","DOI":"10.3389\/fimmu.2014.00380","article-title":"Visceral leishmaniasis: advancements in vaccine development via classical and molecular approaches","volume":"5","author":"Joshi","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cellimm.2024.104826_b0250","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1038\/cti.2014.4","article-title":"Vaccines to prevent leishmaniasis","volume":"3","author":"Kumar","year":"2014","journal-title":"Clin. Transl. Immunol."},{"key":"10.1016\/j.cellimm.2024.104826_b0255","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.actatropica.2011.04.007","article-title":"Studies on the protective efficacy and immunogenicity of Hsp70 and Hsp83 based vaccine formulations in Leishmania donovani infected BALB\/c mice","volume":"119","author":"Kaur","year":"2011","journal-title":"Acta Trop."},{"key":"10.1016\/j.cellimm.2024.104826_b0260","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1007\/s00436-010-2176-4","article-title":"Immunization against leishmaniasis by PLGA nanospheres encapsulated with autoclaved Leishmania major (ALM) and CpG-ODN","volume":"108","author":"Tafaghodi","year":"2011","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.cellimm.2024.104826_b0265","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1365-3024.2010.01253.x","article-title":"Cocktail of gp63 and Hsp70 induces protection against Leishmania donovani in BALB\/c mice","volume":"33","author":"Kaur","year":"2011","journal-title":"Parasite Immunol."},{"key":"10.1016\/j.cellimm.2024.104826_b0270","doi-asserted-by":"crossref","first-page":"5086","DOI":"10.1016\/j.vaccine.2012.05.075","article-title":"Vaccination with Leishmania histone H1-pulsed dendritic cells confers protection in murine visceral leishmaniasis","volume":"30","author":"Agallou","year":"2012","journal-title":"Vaccine."},{"key":"10.1016\/j.cellimm.2024.104826_b0275","doi-asserted-by":"crossref","first-page":"3957","DOI":"10.1016\/j.vaccine.2012.03.040","article-title":"Liposomal SLA co-incorporated with PO CpG ODNs or PS CpG ODNs induce the same protection against the murine model of leishmaniasis","volume":"30","author":"Shargh","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.cellimm.2024.104826_b0280","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1021\/mp2002494","article-title":"Vaccination with liposomal leishmanial antigens adjuvanted with monophosphoryl lipid\u2013trehalose dicorynomycolate (MPL-TDM) confers long-term protection against visceral leishmaniasis through a human administrable route","volume":"9","author":"Ravindran","year":"2012","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.cellimm.2024.104826_b0285","first-page":"209","article-title":"Heat shock proteins enriched-promastigotes of Leishmania major inducing Th2 immune response in BALB\/c mice","volume":"16","author":"Holakuyee","year":"2012","journal-title":"Iran. Biomed. J."},{"key":"10.1016\/j.cellimm.2024.104826_b0290","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.vetpar.2013.09.011","article-title":"Cytokine and nitric oxide patterns in dogs immunized with LBSap vaccine, before and after experimental challenge with Leishmania chagasi plus saliva of Lutzomyia longipalpis","volume":"198","author":"Resende","year":"2013","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.cellimm.2024.104826_b0295","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.actatropica.2013.07.021","article-title":"Induction of protection against leishmaniasis in susceptible BALB\/c mice using simple DOTAP cationic nanoliposomes containing soluble Leishmania antigen (SLA)","volume":"128","author":"Firouzmand","year":"2013","journal-title":"Acta Trop."},{"key":"10.1016\/j.cellimm.2024.104826_b0300","doi-asserted-by":"crossref","first-page":"1","DOI":"10.14411\/fp.2013.001","article-title":"Evaluation of anti-leishmanial effects of killed Leishmania vaccine with BCG adjuvant in BALB\/c mice infected with Leishmania major MRHO\/IR\/75\/ER","volume":"60","author":"Nahrevanian","year":"2013","journal-title":"Folia Parasitol. (Praha)"},{"key":"10.1016\/j.cellimm.2024.104826_b0305","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.imbio.2012.02.008","article-title":"115 kDa serine protease confers sustained protection to visceral leishmaniasis caused by Leishmania donovani via IFN-\u03b3 induced down-regulation of TNF-\u03b1 mediated MMP-9 activity","volume":"218","author":"Choudhury","year":"2013","journal-title":"Immunobiology"},{"key":"10.1016\/j.cellimm.2024.104826_b0310","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s12639-012-0171-7","article-title":"Protective immunity using MPL-A and autoclaved Leishmania donovani as adjuvants along with a cocktail vaccine in murine model of visceral leishmaniasis","volume":"37","author":"Kaur","year":"2013","journal-title":"J. Parasit. Dis."},{"key":"10.1016\/j.cellimm.2024.104826_b0315","first-page":"965","article-title":"Sphingomyelin liposomes containing soluble Leishmania major antigens induced strong Th2 immune response in BALB\/c mice","volume":"16","author":"Chavoshian","year":"2013","journal-title":"Iran. J. Basic Med. Sci."},{"key":"10.1016\/j.cellimm.2024.104826_b0320","first-page":"27","article-title":"Role of imiquimod as adjuvant for vaccination against Leishmania major infection in BALB\/c mice","volume":"1","author":"Dobakhti","year":"2013","journal-title":"J. Med. Microbiol. Infect. Dis."},{"key":"10.1016\/j.cellimm.2024.104826_b0325","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2180-14-8","article-title":"IL-4 contributes to failure, and colludes with IL-10 to exacerbate Leishmania donovani infection following administration of a subcutaneous leishmanial antigen vaccine","volume":"14","author":"Bhowmick","year":"2014","journal-title":"BMC Microbiol."},{"key":"10.1016\/j.cellimm.2024.104826_b0330","first-page":"311","article-title":"Evaluation of alum-naltrexone adjuvant activity, on efficacy of anti-Leishmania immunization with autoclaved Leishmania major (MRHO\/IR\/75\/ER) antigens in BALB\/C mice","volume":"9","author":"Hajipirloo","year":"2014","journal-title":"Iran. J. Parasitol."},{"key":"10.1016\/j.cellimm.2024.104826_b0335","first-page":"669","article-title":"Immunoassay of IL-10 and IL-2 in mice model vaccinated with killed Leishmania major vaccine","volume":"2","author":"Metwally","year":"2014","journal-title":"Int. J."},{"key":"10.1016\/j.cellimm.2024.104826_b0340","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s00430-014-0367-9","article-title":"Evaluation of the immunogenicity and protective efficacy of Killed Leishmania donovani antigen along with different adjuvants against experimental visceral leishmaniasis","volume":"204","author":"Thakur","year":"2015","journal-title":"Med. Microbiol. Immunol."},{"key":"10.1016\/j.cellimm.2024.104826_b0345","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1017\/S0031182015001250","article-title":"Intranasal vaccination with killed Leishmania amazonensis promastigotes antigen (LaAg) associated with CAF01 adjuvant induces partial protection in BALB\/c mice challenged with Leishmania (infantum) chagasi","volume":"142","author":"Leal","year":"2015","journal-title":"Parasitology"},{"key":"10.1016\/j.cellimm.2024.104826_b0350","doi-asserted-by":"crossref","first-page":"e3439","DOI":"10.1371\/journal.pntd.0003439","article-title":"Intranasal vaccination with leishmanial antigens protects golden hamsters (Mesocricetus auratus) against Leishmania (Viannia) braziliensis infection, PLoS Negl","volume":"9","author":"da Silva-Couto","year":"2015","journal-title":"Trop. Dis."},{"key":"10.1016\/j.cellimm.2024.104826_b0355","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.imbio.2015.05.014","article-title":"Studies on the protective efficacy of freeze thawed promastigote antigen of Leishmania donovani along with various adjuvants against visceral leishmaniasis infection in mice","volume":"220","author":"Thakur","year":"2015","journal-title":"Immunobiology"},{"key":"10.1016\/j.cellimm.2024.104826_b0360","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.parint.2014.10.003","article-title":"Evaluation of the immunoprophylactic potential of a killed vaccine candidate in combination with different adjuvants against murine visceral leishmaniasis","volume":"64","author":"Thakur","year":"2015","journal-title":"Parasitol. Int."},{"key":"10.1016\/j.cellimm.2024.104826_b0365","first-page":"601","article-title":"Vaccination against cutaneous leishmaniasis using sonicated and X-ray irradiated promastigote of Leishmania major in murine models","volume":"15","author":"Rahdar","year":"2015","journal-title":"Biochem. Cell. Arch."},{"key":"10.1016\/j.cellimm.2024.104826_b0370","first-page":"274","article-title":"Cationic immune stimulating complexes containing soluble Leishmania antigens: preparation, characterization and in vivo immune response evaluation","volume":"12","author":"Mehravaran","year":"2015","journal-title":"Iran. J. Immunol."},{"key":"10.1016\/j.cellimm.2024.104826_b0375","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.parint.2014.08.004","article-title":"Leishmania donovani phosphoproteins pp41 and pp29 re-establishes host protective immune response in visceral leishmaniasis","volume":"64","author":"Das","year":"2015","journal-title":"Parasitol. Int."},{"key":"10.1016\/j.cellimm.2024.104826_b0380","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/pim.12176","article-title":"Studies on cocktails of 31-kD a, 36-kD a and 51-kD a antigens of Leishmania donovani along with saponin against murine visceral leishmaniasis","volume":"37","author":"Kaur","year":"2015","journal-title":"Parasite Immunol."},{"key":"10.1016\/j.cellimm.2024.104826_b0385","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13071-016-1822-9","article-title":"Efficacy of intranasal LaAg vaccine against Leishmania amazonensis infection in partially resistant C57Bl\/6 mice","volume":"9","author":"Pratti","year":"2016","journal-title":"Parasit. Vectors"},{"key":"10.1016\/j.cellimm.2024.104826_b0390","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jmii.2014.01.006","article-title":"Immunization with antigenic extracts of Leishmania associated with Montanide ISA 763 adjuvant induces partial protection in BALB\/c mice against Leishmania (Leishmania) amazonensis infection","volume":"49","author":"Cargnelutti","year":"2016","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"10.1016\/j.cellimm.2024.104826_b0395","first-page":"573","article-title":"Immunization against cutaneous leishmaniasis by alginate microspheres loaded with autoclaved Leishmania Major (ALM) and Quillaja saponins","volume":"15","author":"Tafaghodi","year":"2016","journal-title":"Iran. J. Pharm. Res. IJPR"},{"key":"10.1016\/j.cellimm.2024.104826_b0400","doi-asserted-by":"crossref","first-page":"6169","DOI":"10.2147\/IJN.S141069","article-title":"Vaccination with poly (D, L-lactide-co-glycolide) nanoparticles loaded with soluble Leishmania antigens and modified with a TNF\u03b1-mimicking peptide or monophosphoryl lipid A confers protection against experimental visceral leishmaniasis","author":"Margaroni","year":"2017","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.cellimm.2024.104826_b0405","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.molimm.2017.09.010","article-title":"Evaluation of the adjuvant effect of agonists of toll-like receptor 4 and 7\/8 in a vaccine against leishmaniasis in BALB\/c mice","volume":"91","author":"Rostamian","year":"2017","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.cellimm.2024.104826_b0410","doi-asserted-by":"crossref","first-page":"e0204491","DOI":"10.1371\/journal.pone.0204491","article-title":"Vaccination with whole-cell killed or recombinant leishmanial protein and toll-like receptor agonists against Leishmania tropica in BALB\/c mice","volume":"13","author":"Rostamian","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.cellimm.2024.104826_b0415","first-page":"11","article-title":"Immunoprophylactic potential of a cocktail of three low molecular weight antigens of Leishmania donovani along with various adjuvants against experimental visceral leishmaniasis","volume":"13","author":"Harpreet","year":"2018","journal-title":"Iran. J. Parasitol."},{"key":"10.1016\/j.cellimm.2024.104826_b0420","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1016\/j.vaccine.2018.03.020","article-title":"Intranasal but not subcutaneous vaccination with LaAg allows rapid expansion of protective immunity against cutaneous leishmaniasis","volume":"36","author":"Bezerra","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.cellimm.2024.104826_b0425","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1080\/21691401.2018.1457042","article-title":"The role of MPL and imiquimod adjuvants in enhancement of immune response and protection in BALB\/c mice immunized with soluble Leishmania antigen (SLA) encapsulated in nanoliposome","volume":"46","author":"Emami","year":"2018","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"10.1016\/j.cellimm.2024.104826_b0430","doi-asserted-by":"crossref","first-page":"3660","DOI":"10.1016\/j.vaccine.2019.05.043","article-title":"Nanoencapsulated retinoic acid as a safe tolerogenic adjuvant for intranasal vaccination against cutaneous leishmaniasis","volume":"37","author":"Bezerra","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.cellimm.2024.104826_b0435","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.meegid.2019.01.005","article-title":"Protection induced by Leishmania major antigens and the imiquimod adjuvant encapsulated on liposomes in experimental cutaneous leishmaniasis","volume":"70","author":"Mehravaran","year":"2019","journal-title":"Infect. Genet. Evol."},{"key":"10.1016\/j.cellimm.2024.104826_b0440","doi-asserted-by":"crossref","first-page":"353","DOI":"10.4103\/1995-7645.262564","article-title":"Evaluation of in vitro and in vivo immunostimulatory activities of poly (lactic-co-glycolic acid) nanoparticles loaded with soluble and autoclaved Leishmania infantum antigens: a novel vaccine candidate against visceral leishmaniasis","volume":"12","author":"Abamor","year":"2019","journal-title":"Asian Pac. J. Trop. Med."},{"key":"10.1016\/j.cellimm.2024.104826_b0445","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.vaccine.2018.11.052","article-title":"Transcutaneous immunization using SLA or rLACK skews the immune response towards a Th1 profile but fails to protect BALB\/c mice against a Leishmania major challenge","volume":"37","author":"Lakhal-Naouar","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.cellimm.2024.104826_b0450","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.micinf.2019.02.005","article-title":"Pam3CSK4 adjuvant given intranasally boosts anti-Leishmania immunogenicity but not protective immune responses conferred by LaAg vaccine against visceral leishmaniasis","volume":"21","author":"Salgado","year":"2019","journal-title":"Microbes Infect."},{"key":"10.1016\/j.cellimm.2024.104826_b0455","first-page":"922","article-title":"Immunogenicity and protection effects of cationic liposome containing imiquimod adjuvant on leishmaniasis in BALB\/c mice","volume":"22","author":"Mehravaran","year":"2019","journal-title":"Iran. J. Basic Med. Sci."},{"key":"10.1016\/j.cellimm.2024.104826_b0460","first-page":"68","article-title":"Evaluation of immune response against leishmaniasis in BALB\/c mice immunized with cationic DOTAP\/DOPE\/CHOL Liposomes containing soluble Leishmania major Antigens","volume":"14","author":"Hojatizade","year":"2019","journal-title":"Iran. J. Parasitol."},{"key":"10.1016\/j.cellimm.2024.104826_b0465","first-page":"64","article-title":"Study of the immune adjuvant effect of chitin microparticles on plasma levels of IgG1 and IgG2a during immunization against Leishmania infection in BALB\/c mice","volume":"43","author":"Azizi","year":"2019","journal-title":"Res. Med."},{"key":"10.1016\/j.cellimm.2024.104826_b0470","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s00430-019-00640-7","article-title":"A new multi-epitope peptide vaccine induces immune responses and protection against Leishmania infantum in BALB\/c mice","volume":"209","author":"Vakili","year":"2020","journal-title":"Med. Microbiol. Immunol."},{"key":"10.1016\/j.cellimm.2024.104826_b0475","article-title":"Liposomes containing the imiquimod adjuvant as a vaccine in the cutaneous leishmaniasis model","volume":"7","author":"Mehravaran","year":"2020","journal-title":"Nanomed. J."},{"key":"10.1016\/j.cellimm.2024.104826_b0480","doi-asserted-by":"crossref","DOI":"10.1016\/j.imbio.2021.152057","article-title":"Immune induction by adjuvanted Leishmania donovani vaccines against the visceral leishmaniasis in BALB\/c mice","volume":"226","author":"Goyal","year":"2021","journal-title":"Immunobiology"},{"key":"10.1016\/j.cellimm.2024.104826_b0485","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2020.111684","article-title":"Nano-co-delivery of lipophosphoglycan with soluble and autoclaved Leishmania antigens into PLGA nanoparticles: evaluation of in vitro and in vivo immunostimulatory effects against visceral leishmaniasis","volume":"120","author":"Tosyali","year":"2021","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.cellimm.2024.104826_b0490","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13071-016-1777-x","article-title":"Differences in immune responses against Leishmania induced by infection and by immunization with killed parasite antigen: implications for vaccine discovery","volume":"9","author":"Mendonca","year":"2016","journal-title":"Parasit. Vectors"},{"key":"10.1016\/j.cellimm.2024.104826_b0495","article-title":"An overview of history, evolution, and manufacturing of various generations of vaccines","volume":"5","author":"Tahamtan","year":"2017","journal-title":"J. Arch. Mil. Med."},{"key":"10.1016\/j.cellimm.2024.104826_b0500","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1080\/21645515.2019.1678998","article-title":"Vaccines for leishmaniasis and the implications of their development for American tegumentary leishmaniasis","volume":"16","author":"Coutinho De Oliveira","year":"2020","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.cellimm.2024.104826_b0505","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.pt.2005.03.006","article-title":"Second-generation vaccines against leishmaniasis","volume":"21","author":"Coler","year":"2005","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.cellimm.2024.104826_b0510","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1086\/315725","article-title":"A Leishmania homologue of receptors for activated C-kinase (LACK) induces both interferon-\u03b3 and interleukin-10 in natural killer cells of healthy blood donors","volume":"182","author":"Maasho","year":"2000","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.cellimm.2024.104826_b0515","doi-asserted-by":"crossref","unstructured":"L.C.C. Afonso, T.M. Scharton, L.Q. Vieira, M. Wysocka, G. Trinchieri, P. Scott, The adjuvant effect of interleukin-12 in a vaccine against Leishmania major, Science (80-.). 263 (1994) 235\u2013237.","DOI":"10.1126\/science.7904381"},{"key":"10.1016\/j.cellimm.2024.104826_b0520","doi-asserted-by":"crossref","first-page":"5726","DOI":"10.1016\/j.vaccine.2012.07.004","article-title":"Oral immunization using live Lactococcus lactis co-expressing LACK and IL-12 protects BALB\/c mice against Leishmania major infection","volume":"30","author":"Hugentobler","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.cellimm.2024.104826_b0525","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0165-2478(95)02473-5","article-title":"Mapping of the linear antigenic determinants from the Leishmania infantum histone H2A recognized by sera from dogs with leishmaniasis","volume":"48","author":"Soto","year":"1995","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.cellimm.2024.104826_b0530","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1128\/CDLI.9.4.808-811.2002","article-title":"Antigenicity of Leishmania braziliensis histone H1 during cutaneous leishmaniasis: localization of antigenic determinants","volume":"9","author":"Carmelo","year":"2002","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.cellimm.2024.104826_b0535","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1111\/j.1365-2958.2006.05205.x","article-title":"Leishmania histone H1 overexpression delays parasite cell-cycle progression, parasite differentiation and reduces Leishmania infectivity in vivo","volume":"60","author":"Smirlis","year":"2006","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.cellimm.2024.104826_b0540","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/j.vaccine.2009.11.075","article-title":"Cellular and humoral responses induced by Leishmania histone H2B and its divergent and conserved parts in cutaneous and visceral leishmaniasis patients, respectively","volume":"28","author":"Meddeb-Garnaoui","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.cellimm.2024.104826_b0545","first-page":"2975","article-title":"Developmental gene expression in Leishmania donovani: differential cloning and analysis of an amastigote-stage-specific gene","volume":"14","author":"Charest","year":"1994","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.cellimm.2024.104826_b0550","doi-asserted-by":"crossref","first-page":"8807","DOI":"10.1073\/pnas.94.16.8807","article-title":"Loss of virulence in Leishmania donovani deficient in an amastigote-specific protein, A2","volume":"94","author":"Zhang","year":"1997","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.cellimm.2024.104826_b0555","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0264-410X(01)00322-X","article-title":"Immunization with A2 protein results in a mixed Th1\/Th2 and a humoral response which protects mice against Leishmania donovani infections","volume":"20","author":"Ghosh","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.cellimm.2024.104826_b0560","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1016\/j.vaccine.2016.03.019","article-title":"Field randomized trial to evaluate the efficacy of the Leish-Tec\u00ae vaccine against canine visceral leishmaniasis in an endemic area of Brazil","volume":"34","author":"Regina-Silva","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.cellimm.2024.104826_b0565","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13071-020-04064-8","article-title":"An immunoinformatic approach driven by experimental proteomics: in silico design of a subunit candidate vaccine targeting secretory proteins of Leishmania donovani amastigotes","volume":"13","author":"Khan","year":"2020","journal-title":"Parasit. Vectors"},{"key":"10.1016\/j.cellimm.2024.104826_b0570","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0966-842X(97)01180-3","article-title":"Lipophosphoglycan (LPG) and the identification of virulence genes in the protozoan parasite Leishmania","volume":"6","author":"Beverley","year":"1998","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.cellimm.2024.104826_b0575","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S1471-4922(01)01895-5","article-title":"Is lipophosphoglycan a virulence factor? A Surprising Diversity between Leishmania Species","volume":"17","author":"Turco","year":"2001","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.cellimm.2024.104826_b0580","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1590\/S0074-02762010000300018","article-title":"Kinetoplastid membrane protein-11 is present in promastigotes and amastigotes of Leishmania amazonensis and its surface expression increases during metacyclogenesis","volume":"105","author":"Matos","year":"2010","journal-title":"Mem. Inst. Oswaldo Cruz."},{"key":"10.1016\/j.cellimm.2024.104826_b0585","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1042\/bj3050307","article-title":"Isolation and structural characterization of the Leishmania donovani kinetoplastid membrane protein-11, a major immunoreactive membrane glycoprotein","volume":"305","author":"Jardim","year":"1995","journal-title":"Biochem. J."},{"key":"10.1016\/j.cellimm.2024.104826_b0590","doi-asserted-by":"crossref","first-page":"7160","DOI":"10.4049\/jimmunol.174.11.7160","article-title":"Kinetoplastid membrane protein-11 DNA vaccination induces complete protection against both pentavalent antimonial-sensitive and-resistant strains of Leishmania donovani that correlates with inducible nitric oxide synthase activity and IL-4 generation: evi","volume":"174","author":"Basu","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellimm.2024.104826_b0595","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2020.155031","article-title":"Leishmania infantum amastin protein incorporated in distinct adjuvant systems induces protection against visceral leishmaniasis","volume":"129","author":"Ribeiro","year":"2020","journal-title":"Cytokine"},{"key":"10.1016\/j.cellimm.2024.104826_b0600","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1128\/CVI.00465-15","article-title":"Proteins selected in Leishmania (Viannia) braziliensis by an immunoproteomic approach with potential serodiagnosis applications for tegumentary leishmaniasis","volume":"22","author":"Duarte","year":"2015","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.cellimm.2024.104826_b0605","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0001430","article-title":"Identification of proteins in promastigote and amastigote-like Leishmania using an immunoproteomic approach","volume":"6","author":"Coelho","year":"2012","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.cellimm.2024.104826_b0610","doi-asserted-by":"crossref","first-page":"3834","DOI":"10.1016\/j.vaccine.2012.03.068","article-title":"Leishmaniasis: vaccine candidates and perspectives","volume":"30","author":"Singh","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.cellimm.2024.104826_b0615","doi-asserted-by":"crossref","first-page":"5491","DOI":"10.1016\/j.vaccine.2010.04.109","article-title":"Serine proteases of Leishmania amazonensis as immunomodulatory and disease-aggravating components of the crude LaAg vaccine","volume":"28","author":"de Matos Guedes","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.cellimm.2024.104826_b0620","doi-asserted-by":"crossref","first-page":"4002","DOI":"10.1016\/j.vaccine.2010.01.015","article-title":"Enhanced efficacy and immunogenicity of 78kDa antigen formulated in various adjuvants against murine visceral leishmaniasis","volume":"28","author":"Nagill","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.cellimm.2024.104826_b0625","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.apjtm.2015.06.008","article-title":"Immunogenicity and efficacy of recombinant 78 kDa antigen of Leishmania donovani formulated in various adjuvants against murine visceral leishmaniasis","volume":"8","author":"Nagill","year":"2015","journal-title":"Asian Pac. J. Trop. Med."},{"key":"10.1016\/j.cellimm.2024.104826_b0630","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0001429","article-title":"Potentiating effects of MPL on DSPC bearing cationic liposomes promote recombinant GP63 vaccine efficacy: high immunogenicity and protection","volume":"5","author":"Mazumder","year":"2011","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.cellimm.2024.104826_b0635","doi-asserted-by":"crossref","first-page":"6417","DOI":"10.4049\/jimmunol.1102081","article-title":"Elongation factor-2, a Th1 stimulatory protein of Leishmania donovani, generates strong IFN-\u03b3 and IL-12 response in cured Leishmania-infected patients\/hamsters and protects hamsters against Leishmania challenge","volume":"187","author":"Kushawaha","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellimm.2024.104826_b0640","doi-asserted-by":"crossref","first-page":"4832","DOI":"10.4049\/jimmunol.1201676","article-title":"Evaluation of recombinant Leishmania polyprotein plus glucopyranosyl lipid A stable emulsion vaccines against sand fly-transmitted Leishmania major in C57BL\/6 mice","volume":"189","author":"Peters","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellimm.2024.104826_b0645","article-title":"Evaluation of Leishmania donovani protein disulfide isomerase as a potential immunogenic protein\/vaccine candidate against visceral leishmaniasis","volume":"7","author":"Kushawaha","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.cellimm.2024.104826_b0650","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0001610","article-title":"KSAC, a defined Leishmania antigen, plus adjuvant protects against the virulence of L. major transmitted by its natural vector Phlebotomus duboscqi","volume":"6","author":"Gomes","year":"2012","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.cellimm.2024.104826_b0655","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.exppara.2012.05.002","article-title":"Leishmania donovani recombinant iron superoxide dismutase B1 protein in the presence of TLR-based adjuvants induces partial protection of BALB\/c mice against Leishmania major infection","volume":"131","author":"Daifalla","year":"2012","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.cellimm.2024.104826_b0660","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/j.vaccine.2012.12.071","article-title":"Evaluation of immune responses and analysis of the effect of vaccination of the Leishmania major recombinant ribosomal proteins L3 or L5 in two different murine models of cutaneous leishmaniasis","volume":"31","author":"Ramirez","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.cellimm.2024.104826_b0665","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/427655ac-c278-41f5-95ca-6279c562752f","article-title":"Antigenicity and protective efficacy of a Leishmania amastigote-specific protein, member of the super-oxygenase family, against visceral leishmaniasis","volume":"7","author":"Martins","year":"2013","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.cellimm.2024.104826_b0670","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1756-3305-7-3","article-title":"Cross-protective effect of a combined L5 plus L3 Leishmania major ribosomal protein based vaccine combined with a Th1 adjuvant in murine cutaneous and visceral leishmaniasis","volume":"7","author":"Ramirez","year":"2014","journal-title":"Parasit. Vectors."},{"key":"10.1016\/j.cellimm.2024.104826_b0675","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003091","article-title":"Combining cationic liposomal delivery with MPL-TDM for cysteine protease cocktail vaccination against Leishmania donovani: evidence for antigen synergy and protection","volume":"8","author":"Das","year":"2014","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.cellimm.2024.104826_b0680","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.parint.2014.07.010","article-title":"Short-term protection conferred by Leishvacin\u00ae against experimental Leishmania amazonensis infection in C57BL\/6 mice","volume":"63","author":"Carneiro","year":"2014","journal-title":"Parasitol. Int."},{"key":"10.1016\/j.cellimm.2024.104826_b0685","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1297-9716-45-69","article-title":"The protective immune response produced in dogs after primary vaccination with the LiESP\/QA-21 vaccine (CaniLeish\u00ae) remains effective against an experimental challenge one year later","volume":"45","author":"Martin","year":"2014","journal-title":"Vet. Res."},{"key":"10.1016\/j.cellimm.2024.104826_b0690","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/j.vaccine.2014.01.024","article-title":"Immunization with the Leishmania infantum recombinant cyclophilin protein 1 confers partial protection to subsequent parasite infection and generates specific memory T cells","volume":"32","author":"Santos-Gomes","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.cellimm.2024.104826_b0695","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13071-015-0964-5","article-title":"A Leishmania-specific hypothetical protein expressed in both promastigote and amastigote stages of Leishmania infantum employed for the serodiagnosis of, and as a vaccine candidate against, visceral leishmaniasis","volume":"8","author":"Martins","year":"2015","journal-title":"Parasit. Vectors."},{"key":"10.1016\/j.cellimm.2024.104826_b0700","doi-asserted-by":"crossref","first-page":"290ra90","DOI":"10.1126\/scitranslmed.aaa3043","article-title":"A sand fly salivary protein vaccine shows efficacy against vector-transmitted cutaneous leishmaniasis in nonhuman primates","volume":"7","author":"Oliveira","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.cellimm.2024.104826_b0705","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.molimm.2015.08.001","article-title":"Leishmania tarentolae secreting the sand fly salivary antigen PpSP15 confers protection against Leishmania major infection in a susceptible BALB\/c mice model","volume":"67","author":"Katebi","year":"2015","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.cellimm.2024.104826_b0710","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1017\/S0031182015000724","article-title":"Phage-fused epitopes from Leishmania infantum used as immunogenic vaccines confer partial protection against Leishmania amazonensis infection","volume":"142","author":"Costa","year":"2015","journal-title":"Parasitology"},{"key":"10.1016\/j.cellimm.2024.104826_b0715","doi-asserted-by":"crossref","first-page":"e0137683","DOI":"10.1371\/journal.pone.0137683","article-title":"Antigenicity, immunogenicity and protective efficacy of three proteins expressed in the promastigote and amastigote stages of Leishmania infantum against visceral leishmaniasis","volume":"10","author":"Martins","year":"2015","journal-title":"PLoS One."},{"key":"10.1016\/j.cellimm.2024.104826_b0720","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1111\/pim.12287","article-title":"Prophylactic properties of a Leishmania-specific hypothetical protein in a murine model of visceral leishmaniasis","volume":"37","author":"Lage","year":"2015","journal-title":"Parasite Immunol."},{"key":"10.1016\/j.cellimm.2024.104826_b0725","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.exppara.2015.03.027","article-title":"Evaluation of adjuvant activity of fractions derived from Agaricus blazei, when in association with the recombinant LiHyp1 protein, to protect against visceral leishmaniasis","volume":"153","author":"de Jesus Pereira","year":"2015","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.cellimm.2024.104826_b0730","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.molimm.2016.06.014","article-title":"A vaccine combining two Leishmania braziliensis proteins offers heterologous protection against Leishmania infantum infection","volume":"76","author":"Duarte","year":"2016","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.cellimm.2024.104826_b0735","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.actatropica.2015.11.006","article-title":"A new Leishmania-specific hypothetical protein, LiHyT, used as a vaccine antigen against visceral leishmaniasis","volume":"154","author":"Martins","year":"2016","journal-title":"Acta Trop."},{"key":"10.1016\/j.cellimm.2024.104826_b0740","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.actatropica.2016.03.011","article-title":"Cross-protective efficacy of Leishmania infantum LiHyD protein against tegumentary leishmaniasis caused by Leishmania major and Leishmania braziliensis species","volume":"158","author":"Lage","year":"2016","journal-title":"Acta Trop."},{"key":"10.1016\/j.cellimm.2024.104826_b0745","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1007\/s12639-014-0574-8","article-title":"The role of Montanide ISA 70 as an adjuvant in immune responses against Leishmania major induced by thiol-specific antioxidant-based protein vaccine","volume":"40","author":"Khabazzadeh Tehrani","year":"2016","journal-title":"J. Parasit. Dis."},{"key":"10.1016\/j.cellimm.2024.104826_b0750","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/pim.12304","article-title":"Cross-protective efficacy from a immunogen firstly identified in Leishmania infantum against tegumentary leishmaniasis","volume":"38","author":"Martins","year":"2016","journal-title":"Parasite Immunol."},{"key":"10.1016\/j.cellimm.2024.104826_b0755","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.trivac.2015.11.001","article-title":"Immunogenicity in dogs and protection against visceral leishmaniasis induced by a 14 kDa Leishmania infantum recombinant polypeptide","volume":"5","author":"Abeijon","year":"2016","journal-title":"Trials Vaccinol."},{"key":"10.1016\/j.cellimm.2024.104826_b0760","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.molimm.2016.06.010","article-title":"Comparing Montanide ISA 720 and 50\u2013V2 adjuvants formulated with LmSTI1 protein of Leishmania major indicated the potential cytokine patterns for induction of protective immune responses in BALB\/c mice","volume":"76","author":"Shokri","year":"2016","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.cellimm.2024.104826_b0765","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/sji.12557","article-title":"A non-pathogenic recombinant Leishmania expressing Lipophosphoglycan 3 against experimental infection with Leishmania infantum","volume":"86","author":"Pirdel","year":"2017","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.cellimm.2024.104826_b0770","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.imbio.2016.09.015","article-title":"A vaccine composed of a hypothetical protein and the eukaryotic initiation factor 5a from Leishmania braziliensis cross-protection against Leishmania amazonensis infection","volume":"222","author":"Duarte","year":"2017","journal-title":"Immunobiology."},{"key":"10.1016\/j.cellimm.2024.104826_b0775","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.pep.2016.10.008","article-title":"Expression, purification, immunogenicity and protective efficacy of a recombinant nucleoside hydrolase from Leishmania donovani, a vaccine candidate for preventing cutaneous leishmaniasis","volume":"130","author":"McAtee","year":"2017","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.cellimm.2024.104826_b0780","doi-asserted-by":"crossref","first-page":"e12345","DOI":"10.1111\/pim.12345","article-title":"Immune response to recombinant Leishmania infantum lipophosphoglycan 3 plus CpG oligodeoxynucleotides in BALB\/c mice","volume":"39","author":"Pirdel","year":"2017","journal-title":"Parasite Immunol."},{"key":"10.1016\/j.cellimm.2024.104826_b0785","doi-asserted-by":"crossref","first-page":"e12359","DOI":"10.1111\/pim.12359","article-title":"A recombinant chimeric protein composed of human and mice-specific CD 4+ and CD 8+ T-cell epitopes protects against visceral leishmaniasis","volume":"39","author":"Martins","year":"2017","journal-title":"Parasite Immunol."},{"key":"10.1016\/j.cellimm.2024.104826_b0790","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.cellimm.2017.11.001","article-title":"Recombinant prohibitin protein of Leishmania infantum acts as a vaccine candidate and diagnostic marker against visceral leishmaniasis","volume":"323","author":"Dias","year":"2018","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.cellimm.2024.104826_b0795","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.cellimm.2018.05.009","article-title":"Evaluation of a Leishmania hypothetical protein administered as DNA vaccine or recombinant protein against Leishmania infantum infection and its immunogenicity in humans","volume":"331","author":"Ribeiro","year":"2018","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.cellimm.2024.104826_b0800","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1017\/S0031182017001731","article-title":"Antigenicity, immunogenicity and protective efficacy of a conserved Leishmania hypothetical protein against visceral leishmaniasis","volume":"145","author":"Dias","year":"2018","journal-title":"Parasitology."},{"key":"10.1016\/j.cellimm.2024.104826_b0805","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.micinf.2017.09.011","article-title":"Leishmania donovani serine protease encapsulated in liposome elicits protective immunity in experimental visceral leishmaniasis","volume":"20","author":"Das","year":"2018","journal-title":"Microbes Infect."},{"key":"10.1016\/j.cellimm.2024.104826_b0810","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41541-020-00224-0","article-title":"A candidate vaccine for human visceral leishmaniasis based on a specific T cell epitope-containing chimeric protein protects mice against Leishmania infantum infection","volume":"5","author":"Lage","year":"2020","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.cellimm.2024.104826_b0815","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119390","article-title":"A TLR9-adjuvanted vaccine formulated into dissolvable microneedle patches or cationic liposomes protects against leishmaniasis after skin or subcutaneous immunization","volume":"586","author":"Lanza","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.cellimm.2024.104826_b0820","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.molimm.2020.06.010","article-title":"Leishmania infantum pyridoxal kinase evaluated in a recombinant protein and DNA vaccine to protects against visceral leishmaniasis","volume":"124","author":"Oliveira-da-Silva","year":"2020","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.cellimm.2024.104826_b0825","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellimm.2020.104194","article-title":"A Leishmania amastigote-specific hypothetical protein evaluated as recombinant protein plus Th1 adjuvant or DNA plasmid-based vaccine to protect against visceral leishmaniasis","volume":"356","author":"Oliveira-da-Silva","year":"2020","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.cellimm.2024.104826_b0830","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110097","article-title":"Lipophosphoglycan-3 recombinant protein vaccine controls hepatic parasitism and prevents tissue damage in mice infected by Leishmania infantum chagasi","volume":"126","author":"Bastos","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.cellimm.2024.104826_b0835","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1007\/s00436-020-06752-x","article-title":"Evaluation of the protective efficacy of a Leishmania protein associated with distinct adjuvants against visceral leishmaniasis and in vitro immunogenicity in human cells","volume":"119","author":"Ribeiro","year":"2020","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.cellimm.2024.104826_b0840","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1016\/j.vaccine.2021.04.004","article-title":"A chimeric vaccine combined with adjuvant system induces immunogenicity and protection against visceral leishmaniasis in BALB\/c mice","volume":"39","author":"Ostolin","year":"2021","journal-title":"Vaccine."},{"key":"10.1016\/j.cellimm.2024.104826_b0845","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2021\/8845826","article-title":"A Chimera of Th1 stimulatory proteins of Leishmania donovani offers moderate immunotherapeutic efficacy with a Th1-inclined immune response against visceral leishmaniasis","volume":"2021","author":"Ratnapriya","year":"2021","journal-title":"Biomed Res. Int."},{"key":"10.1016\/j.cellimm.2024.104826_b0850","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellimm.2020.104272","article-title":"IFN-\u03b3+ CD4+ T cell-driven prophylactic potential of recombinant LDBPK_252400 hypothetical protein of Leishmania donovani against visceral leishmaniasis","volume":"361","author":"Yadav","year":"2021","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.cellimm.2024.104826_b0855","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2021.104745","article-title":"Leishmania eukaryotic elongation Factor-1 beta protein is immunogenic and induces parasitological protection in mice against Leishmania infantum infection","volume":"151","author":"Santos","year":"2021","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.cellimm.2024.104826_b0860","article-title":"Multi-antigen vaccination with LPD nanoparticles containing rgp63 and rLmaC1N proteins induced effective immune response against leishmaniasis in animal model","volume":"64","author":"Zamani","year":"2021","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.cellimm.2024.104826_b0865","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellimm.2022.104529","article-title":"Dipeptidylcarboxypeptidase of Leishmania donovani: A potential vaccine molecule against experimental visceral leishmaniasis","volume":"375","author":"Balodi","year":"2022","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.cellimm.2024.104826_b0870","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.3390\/vaccines10071146","article-title":"A recombinant chimeric protein-based vaccine containing T-cell epitopes from amastigote proteins and combined with distinct adjuvants, induces immunogenicity and protection against Leishmania infantum infection","volume":"10","author":"Lage","year":"2022","journal-title":"Vaccines."},{"key":"10.1016\/j.cellimm.2024.104826_b0875","article-title":"A specific Leishmania infantum polyepitope vaccine triggers Th1-type immune response and protects against experimental visceral leishmaniasis","volume":"380","author":"Ostolin","year":"2022","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.cellimm.2024.104826_b0880","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.molimm.2021.11.009","article-title":"Immunological characterization of rLdTCP1\u03b3 for its prophylactic potential against visceral leishmaniasis in hamster model","volume":"141","author":"Anand","year":"2022","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.cellimm.2024.104826_b0885","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2022.155865","article-title":"Recombinant guanosine-5\u2032-triphosphate (GTP)-binding protein associated with Poloxamer 407-based polymeric micelles protects against Leishmania infantum infection","volume":"153","author":"Lage","year":"2022","journal-title":"Cytokine."},{"key":"10.1016\/j.cellimm.2024.104826_b0890","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1016\/j.vaccine.2013.01.048","article-title":"Induction of immunogenicity by live attenuated Leishmania donovani centrin deleted parasites in dogs","volume":"31","author":"Fiuza","year":"2013","journal-title":"Vaccine."},{"key":"10.1016\/j.cellimm.2024.104826_b0895","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.1016\/j.vaccine.2019.04.068","article-title":"Leishmania major p27 gene knockout as a novel live attenuated vaccine candidate: protective immunity and efficacy evaluation against cutaneous and visceral leishmaniasis in BALB\/c mice","volume":"37","author":"Elikaee","year":"2019","journal-title":"Vaccine."},{"key":"10.1016\/j.cellimm.2024.104826_b0900","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1038\/s42003-021-02446-x","article-title":"Preclinical validation of a live attenuated dermotropic Leishmania vaccine against vector transmitted fatal visceral leishmaniasis","volume":"4","author":"Karmakar","year":"2021","journal-title":"Commun. Biol."},{"key":"10.1016\/j.cellimm.2024.104826_b0905","doi-asserted-by":"crossref","first-page":"288","DOI":"10.3389\/fimmu.2019.00288","article-title":"Immunogenicity and protective efficacy of T-cell epitopes derived from potential Th1 stimulatory proteins of Leishmania (Leishmania) donovani","volume":"10","author":"Joshi","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cellimm.2024.104826_b0910","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.bbrc.2003.10.148","article-title":"A putative coiled-coil domain of prohibitin is sufficient to repress E2F1-mediated transcription and induce apoptosis","volume":"312","author":"Joshi","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cellimm.2024.104826_b0915","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1093\/emboj\/19.11.2444","article-title":"Prohibitins act as a membrane-bound chaperone for the stabilization of mitochondrial proteins","volume":"19","author":"Nijtmans","year":"2000","journal-title":"EMBO J."},{"key":"10.1016\/j.cellimm.2024.104826_b0920","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/j.1462-5822.2009.01406.x","article-title":"Leishmania cell surface prohibitin: role in host\u2013parasite interaction","volume":"12","author":"Jain","year":"2010","journal-title":"Cell. Microbiol."},{"key":"10.1016\/j.cellimm.2024.104826_b0925","doi-asserted-by":"crossref","first-page":"3461","DOI":"10.1038\/s41467-020-17154-z","article-title":"A second generation leishmanization vaccine with a markerless attenuated Leishmania major strain using CRISPR gene editing","volume":"11","author":"Zhang","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cellimm.2024.104826_b0930","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/s41541-022-00449-1","article-title":"Centrin-deficient Leishmania mexicana confers protection against New World cutaneous leishmaniasis","volume":"7","author":"Volpedo","year":"2022","journal-title":"NPJ Vaccines."},{"key":"10.1016\/j.cellimm.2024.104826_b0935","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/s41541-022-00574-x","article-title":"Centrin-deficient Leishmania mexicana confers protection against Old World visceral leishmaniasis","volume":"7","author":"Karmakar","year":"2022","journal-title":"NPJ Vaccines."},{"key":"10.1016\/j.cellimm.2024.104826_b0940","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1586\/erv.11.29","article-title":"Recent clinical experience with vaccines using MPL-and QS-21-containing adjuvant systems","volume":"10","author":"Garcon","year":"2011","journal-title":"Expert Rev. Vaccines."},{"key":"10.1016\/j.cellimm.2024.104826_b0945","doi-asserted-by":"crossref","first-page":"s32","DOI":"10.1016\/S0966-842X(02)02426-5","article-title":"Taking toll: lipid A mimetics as adjuvants and immunomodulators","volume":"10","author":"Persing","year":"2002","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.cellimm.2024.104826_b0950","doi-asserted-by":"crossref","first-page":"3531","DOI":"10.1016\/j.vaccine.2011.02.096","article-title":"A clinical trial to evaluate the safety and immunogenicity of the LEISH-F1+ MPL-SE vaccine for use in the prevention of visceral leishmaniasis","volume":"29","author":"Chakravarty","year":"2011","journal-title":"Vaccine."},{"issue":"1996","key":"10.1016\/j.cellimm.2024.104826_b0955","first-page":"5034","article-title":"Molecular cloning of a novel protein antigen of Leishmania major that elicits a potent immune response in experimental murine leishmaniasis","volume":"157","author":"Webb","year":"1950","journal-title":"J. Immunol. (baltimore, Md."},{"key":"10.1016\/j.cellimm.2024.104826_b0960","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.molbiopara.2003.12.004","article-title":"Genomic organization and gene expression in a chromosomal region of Leishmania major","volume":"134","author":"Monnerat","year":"2004","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.cellimm.2024.104826_b0965","doi-asserted-by":"crossref","first-page":"5086","DOI":"10.1111\/j.1742-4658.2006.05506.x","article-title":"Leishmania infantum LeIF protein is an ATP-dependent RNA helicase and an eIF4A-like factor that inhibits translation in yeast","volume":"273","author":"Barhoumi","year":"2006","journal-title":"FEBS J."},{"key":"10.1016\/j.cellimm.2024.104826_b0970","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.gene.2005.10.019","article-title":"The DEAD-box protein family of RNA helicases","volume":"367","author":"Cordin","year":"2006","journal-title":"Gene."},{"key":"10.1016\/j.cellimm.2024.104826_b0975","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0962-8924(94)90210-0","article-title":"RNA helicases: modulators of RNA structure","volume":"4","author":"Fuller-Pace","year":"1994","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.cellimm.2024.104826_b0980","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.it.2008.09.006","article-title":"New horizons in adjuvants for vaccine development","volume":"30","author":"Reed","year":"2009","journal-title":"Trends Immunol."},{"key":"10.1016\/j.cellimm.2024.104826_b0985","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.1016\/j.vaccine.2015.12.071","article-title":"Status of vaccine research and development of vaccines for leishmaniasis","volume":"34","author":"Gillespie","year":"2016","journal-title":"Vaccine."},{"key":"10.1016\/j.cellimm.2024.104826_b0990","doi-asserted-by":"crossref","first-page":"4255","DOI":"10.1016\/j.vaccine.2017.06.013","article-title":"CD11a and CD49d enhance the detection of antigen-specific T cells following human vaccination","volume":"35","author":"Christiaansen","year":"2017","journal-title":"Vaccine."},{"key":"10.1016\/j.cellimm.2024.104826_b0995","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1038\/cti.2015.6","article-title":"From mouse to man: safety, immunogenicity and efficacy of a candidate leishmaniasis vaccine LEISH-F3+ GLA-SE","volume":"4","author":"Coler","year":"2015","journal-title":"Clin. Transl. Immunol."},{"key":"10.1016\/j.cellimm.2024.104826_b1000","doi-asserted-by":"crossref","first-page":"4216","DOI":"10.1016\/j.vaccine.2012.04.051","article-title":"Intradermally administered TLR4 agonist GLA-SE enhances the capacity of human skin DCs to activate T cells and promotes emigration of Langerhans cells","volume":"30","author":"Schneider","year":"2012","journal-title":"Vaccine."},{"key":"10.1016\/j.cellimm.2024.104826_b1005","doi-asserted-by":"crossref","first-page":"3505","DOI":"10.1016\/j.vaccine.2019.04.092","article-title":"Visceral leishmaniasis: an overview of vaccine adjuvants and their applications","volume":"37","author":"Ratnapriya","year":"2019","journal-title":"Vaccine."},{"key":"10.1016\/j.cellimm.2024.104826_b1010","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.actatropica.2016.04.004","article-title":"Coadminstration of L. major amastigote class I nuclease (rLmaCIN) with LPD nanoparticles delays the progression of skin lesion and the L. major dissemination to the spleen in BALB\/c mice-based experimental setting","volume":"159","author":"Fakhraee","year":"2016","journal-title":"Acta Trop."},{"key":"10.1016\/j.cellimm.2024.104826_b1015","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/j.1365-2249.2004.02702.x","article-title":"Mononuclear cells from patients recovered from cutaneous leishmaniasis respond to Leishmania major amastigote class I nuclease with a predominant Th1-like response","volume":"139","author":"Farajnia","year":"2005","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.cellimm.2024.104826_b1020","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2147\/DDDT.S146521","article-title":"Leishmaniasis in humans: drug or vaccine therapy?","author":"Ghorbani","year":"2017","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.cellimm.2024.104826_b1025","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jconrel.2011.04.011","article-title":"Delivery of a cocktail DNA vaccine encoding cysteine proteinases type I, II and III with solid lipid nanoparticles potentiate protective immunity against Leishmania major infection","volume":"153","author":"Doroud","year":"2011","journal-title":"J. Control. Release."},{"key":"10.1016\/j.cellimm.2024.104826_b1030","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.actatropica.2011.08.007","article-title":"DNA vaccination with KMP11 and Lutzomyia longipalpis salivary protein protects hamsters against visceral leishmaniasis","volume":"120","author":"da Silva","year":"2011","journal-title":"Acta Trop."},{"key":"10.1016\/j.cellimm.2024.104826_b1035","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.cimid.2011.06.002","article-title":"Mechanisms of immunity to Leishmania major infection in mice: The contribution of DNA vaccines coding for two novel sets of histones (H2A\u2013H2B or H3\u2013H4)","volume":"34","author":"Carrion","year":"2011","journal-title":"Comp. Immunol. Microbiol. Infect. Dis."},{"key":"10.1016\/j.cellimm.2024.104826_b1040","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1017\/S0031182011001417","article-title":"Intranasal immunization with LACK-DNA promotes protective immunity in hamsters challenged with Leishmania chagasi","volume":"138","author":"De Oliveira Gomes","year":"2011","journal-title":"Parasitology-Cambridge."},{"key":"10.1016\/j.cellimm.2024.104826_b1045","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/j.1600-0463.2012.02968.x","article-title":"Enhancement of immune response induced by DNA vaccine cocktail expressing complete LACK and TSA genes against Leishmania major","volume":"121","author":"Ghaffarifar","year":"2013","journal-title":"Apmis."},{"key":"10.1016\/j.cellimm.2024.104826_b1050","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.exppara.2013.03.012","article-title":"Effect of IL-22 on DNA vaccine encoding LACK gene of Leishmania major in BALB\/c mice","volume":"134","author":"Hezarjaribi","year":"2013","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.cellimm.2024.104826_b1055","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/pim.12042","article-title":"Cationic solid\u2013lipid nanoparticles are as efficient as electroporation in DNA vaccination against visceral leishmaniasis in mice","volume":"35","author":"Saljoughian","year":"2013","journal-title":"Parasite Immunol."},{"key":"10.1016\/j.cellimm.2024.104826_b1060","doi-asserted-by":"crossref","DOI":"10.5812\/jjm.8974","article-title":"Th1 platform immune responses against Leishmania major induced by thiol-specific antioxidant-based DNA vaccines","volume":"7","author":"Tabatabaie","year":"2014","journal-title":"Jundishapur J. Microbiol."},{"key":"10.1016\/j.cellimm.2024.104826_b1065","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1111\/pim.12147","article-title":"Immune response in susceptible BALB\/c mice immunized with DNA encoding Lipophosphoglycan 3 of Leishmania infantum","volume":"36","author":"Pirdel","year":"2014","journal-title":"Parasite Immunol."},{"key":"10.1016\/j.cellimm.2024.104826_b1070","doi-asserted-by":"crossref","first-page":"e0003751","DOI":"10.1371\/journal.pntd.0003751","article-title":"Coadministration of the three antigenic Leishmania infantum Poly (A) Binding Proteins as a DNA vaccine induces protection against Leishmania major infection in BALB\/c Mice","volume":"9","author":"Soto","year":"2015","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.cellimm.2024.104826_b1075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003490","article-title":"Vaccination with Leishmania infantum acidic ribosomal P0 but not with nucleosomal histones proteins controls Leishmania infantum infection in hamsters, PLoS Negl","volume":"9","author":"Pereira","year":"2015","journal-title":"Trop. Dis."},{"key":"10.1016\/j.cellimm.2024.104826_b1080","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s12639-014-0521-8","article-title":"Immune responses in DNA vaccine formulated with PMMA following immunization and after challenge with Leishmania major","volume":"40","author":"Zarrati","year":"2016","journal-title":"J. Parasit. Dis."},{"key":"10.1016\/j.cellimm.2024.104826_b1085","doi-asserted-by":"crossref","first-page":"304","DOI":"10.7555\/JBR.30.20150125","article-title":"Immunogenicity and protective efficacy of DNA vaccine against visceral leishmaniasis in BALB\/c mice","volume":"30","author":"Kaur","year":"2016","journal-title":"J. Biomed. Res."},{"key":"10.1016\/j.cellimm.2024.104826_b1090","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/pim.12310","article-title":"Codelivery of DNA vaccination encoding Le IF gene and IL-12 increases protection against Leishmania major infection in BALB\/c mice","volume":"38","author":"Maspi","year":"2016","journal-title":"Parasite Immunol."},{"key":"10.1016\/j.cellimm.2024.104826_b1095","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/apm.12651","article-title":"Immunogenicity and efficacy of a bivalent DNA vaccine containing LeIF and TSA genes against murine cutaneous leishmaniasis","volume":"125","author":"Maspi","year":"2017","journal-title":"Apmis."},{"key":"10.1016\/j.cellimm.2024.104826_b1100","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.molimm.2016.12.022","article-title":"Immunization with Leishmania donovani protein disulfide isomerase DNA construct induces Th1 and Th17 dependent immune response and protection against experimental visceral leishmaniasis in BALB\/c mice","volume":"82","author":"Amit","year":"2017","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.cellimm.2024.104826_b1105","first-page":"267","article-title":"DNA vaccination with a plasmid encoding LACK-TSA fusion against Leishmania major infection in BALB\/c mice","volume":"39","author":"Maspi","year":"2017","journal-title":"Malays. J. Pathol."},{"key":"10.1016\/j.cellimm.2024.104826_b1110","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s00005-017-0484-4","article-title":"Comparative assessment of induced immune responses following intramuscular immunization with fusion and cocktail of LeIF, LACK and TSA genes against cutaneous leishmaniasis in BALB\/c mice","volume":"66","author":"Maspi","year":"2018","journal-title":"Arch. Immunol. Ther. Exp. (warsz)"},{"key":"10.1016\/j.cellimm.2024.104826_b1115","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3390\/vaccines7040183","article-title":"Immunization with the HisAK70 DNA Vaccine induces resistance against Leishmania amazonensis infection in BALB\/c mice","volume":"7","author":"Martinez-Rodrigo","year":"2019","journal-title":"Vaccines."},{"key":"10.1016\/j.cellimm.2024.104826_b1120","first-page":"1493","article-title":"Immunization against Leishmania major infection in BALB\/c mice using a subunit-based DNA vaccine derived from TSA, LmSTI1, KMP11, and LACK predominant antigens","volume":"22","author":"Salehi-Sangani","year":"2019","journal-title":"Iran. J. Basic Med. Sci."},{"key":"10.1016\/j.cellimm.2024.104826_b1125","doi-asserted-by":"crossref","DOI":"10.1016\/j.micinf.2021.104884","article-title":"Intranasal immunization with chitosan microparticles enhances LACK-DNA vaccine protection and induces specific long-lasting immunity against visceral leishmaniasis","volume":"24","author":"Gomes","year":"2022","journal-title":"Microbes Infect."},{"key":"10.1016\/j.cellimm.2024.104826_b1130","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0035-9203(03)90171-4","article-title":"Alum-precipitated autoclaved Leishmania major plus Bacille Calmette-Guerrin, a candidate vaccine for visceral leishmaniasis: safety, skin-delayed type hypersensitivity response and dose finding in healthy volunteers","volume":"97","author":"Kamil","year":"2003","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.cellimm.2024.104826_b1135","doi-asserted-by":"crossref","first-page":"e0005527","DOI":"10.1371\/journal.pntd.0005527","article-title":"A third generation vaccine for human visceral leishmaniasis and post kala azar dermal leishmaniasis: First-in-human trial of ChAd63-KH","volume":"11","author":"Osman","year":"2017","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.cellimm.2024.104826_b1140","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/s41541-019-0144-2","article-title":"Peptide-based vaccine successfully induces protective immunity against canine visceral leishmaniasis","volume":"4","author":"Petitdidier","year":"2019","journal-title":"Npj Vaccines."},{"key":"10.1016\/j.cellimm.2024.104826_b1145","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/tmi.13382","article-title":"Commercially approved vaccines for canine leishmaniosis: a review of available data on their safety and efficacy","volume":"25","author":"Velez","year":"2020","journal-title":"Trop. Med. Int. Heal."},{"key":"10.1016\/j.cellimm.2024.104826_b1150","doi-asserted-by":"crossref","first-page":"5493","DOI":"10.1016\/S0021-9258(17)37485-9","article-title":"Protein EnvM is the NADH-dependent enoyl-ACP reductase (FabI) of Escherichia coli","volume":"269","author":"Bergler","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cellimm.2024.104826_b1155","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.plasmid.2018.12.002","article-title":"The antibiotic resistance-free mammalian expression plasmid vector pPAL for development of third generation vaccines","volume":"101","author":"Alcolea","year":"2019","journal-title":"Plasmid."},{"key":"10.1016\/j.cellimm.2024.104826_b1160","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1017\/S0031182015001079","article-title":"Immunomics: a 21st century approach to vaccine development for complex pathogens","volume":"143","author":"De Sousa","year":"2016","journal-title":"Parasitology."},{"key":"10.1016\/j.cellimm.2024.104826_b1165","doi-asserted-by":"crossref","first-page":"122","DOI":"10.3390\/vaccines7040122","article-title":"Enlisting the mRNA vaccine platform to combat parasitic infections","volume":"7","author":"Versteeg","year":"2019","journal-title":"Vaccines."},{"key":"10.1016\/j.cellimm.2024.104826_b1170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13071-016-1553-y","article-title":"Possibilities and challenges for developing a successful vaccine for leishmaniasis","volume":"9","author":"Srivastava","year":"2016","journal-title":"Parasit. Vectors."},{"key":"10.1016\/j.cellimm.2024.104826_b1175","doi-asserted-by":"crossref","first-page":"S153","DOI":"10.1016\/j.vaccine.2023.01.057","article-title":"Vaccine value profile for leishmaniasis","volume":"41","author":"Kaye","year":"2023","journal-title":"Vaccine."},{"key":"10.1016\/j.cellimm.2024.104826_b1180","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1128\/JCM.00372-14","article-title":"Molecular tools for diagnosis of visceral leishmaniasis: systematic review and meta-analysis of diagnostic test accuracy","volume":"52","author":"De Ruiter","year":"2014","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.cellimm.2024.104826_b1185","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1128\/CMR.14.2.229-243.2001","article-title":"Leishmaniasis: current status of vaccine development","volume":"14","author":"Handman","year":"2001","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.cellimm.2024.104826_b1190","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1590\/0037-8682-0343-2016","article-title":"The challenges on developing vaccine against visceral leishmaniasis","volume":"49","author":"Jeronimo","year":"2016","journal-title":"Rev. Soc. Bras. Med. Trop."},{"key":"10.1016\/j.cellimm.2024.104826_b1195","first-page":"5582","article-title":"Do parasite infections interfere with immunisation?","volume":"38","author":"Wait","year":"2020","journal-title":"A Review and Meta-Analysis, Vaccine."},{"key":"10.1016\/j.cellimm.2024.104826_b1200","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.847797","article-title":"Major molecular factors related to Leishmania pathogenicity","volume":"13","author":"Al-Khalaifah","year":"2022","journal-title":"Front. Immunol."}],"container-title":["Cellular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008874924000297?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008874924000297?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T09:27:18Z","timestamp":1730107638000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0008874924000297"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":240,"alternative-id":["S0008874924000297"],"URL":"https:\/\/doi.org\/10.1016\/j.cellimm.2024.104826","relation":{},"ISSN":["0008-8749"],"issn-type":[{"value":"0008-8749","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Leishmania vaccine development: A comprehensive review","name":"articletitle","label":"Article Title"},{"value":"Cellular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellimm.2024.104826","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104826"}}